Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
Figure 9
In vitro release profile of atenolol from the prepared bilayer tablets performed in 0.1 M HCl of pH 1.2 at °C (mean ± S.E.; ).
